| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,609 |
8,508 |
$654K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,456 |
1,347 |
$145K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,339 |
1,339 |
$136K |
| 73630 |
|
4,625 |
3,590 |
$118K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
276 |
275 |
$42K |
| 73610 |
|
873 |
716 |
$24K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
112 |
56 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
38 |
37 |
$2K |
| 99072 |
|
524 |
448 |
$536.50 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
42 |
38 |
$494.29 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
17 |
17 |
$225.12 |
| 99024 |
|
184 |
134 |
$0.00 |